New drug trial offers hope for Tough-to-Treat brain tumors
Disease control
Not yet recruiting
This study is testing whether an experimental drug called zanzalintinib can help control recurrent meningioma brain tumors that have continued growing despite standard treatments like surgery and radiation. The trial will enroll 100 adults whose tumors have returned or progressed…
Phase: PHASE2 • Sponsor: Exelixis • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC